✦ LIBER ✦

Stop-tag a multicenter randomised control trial comparing balneotherapy versus paroxetine in the treatment of generalized anxiety disorder

✍ Scribed by Dubois, O.

Book ID: 124115629
Publisher: Elsevier
Year: 2014
Tongue: French
Weight: 372 KB
Volume: 57
Category: Article
ISSN: 1877-0657
DOI: 10.1016/j.rehab.2014.03.584

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Balneotherapy versus paroxetine in the t

Balneotherapy versus paroxetine in the treatment of generalized anxiety disorder

✍ Olivier Dubois; Roger Salamon; Christine Germain; Marie-France Poirier; Christia 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Ritanserin in the treatment of generaliz

Ritanserin in the treatment of generalized anxiety disorders: A placebo-controlled trial

✍ E. A. Pangalila-Ratu Langi; A. A. I. Jansen 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 2 views

In a double-blind trial, 22 patients treated with 5 mg b.i.d. of the selective serotonin-S2 antagonist ritanserin for 4 weeks were compared with 26 patients treated with placebo for generalized anxiety disorder (DSM 111: 300.02). Symptoms were assessed using the Hamilton Anxiety Rating Scale (HARS)

Depression in the course of treatment of

Depression in the course of treatment of generalized anxiety disorder with lorazepam, ipsapirone, and placebo: Results from a multicenter trial

✍ John J. Sramek; Neal R. Cutler; Jerome F. Costa; Jan M. Keppel Hesselink; Randal 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB

Paroxetine is effective in the treatment

Paroxetine is effective in the treatment of generalized anxiety disorder: results from a randomized placebo-controlled flexible dose study

✍ J.P. McCafferty; K. Bellew; R. Zanelli; M. Iyengar; K. Hewett 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Multicenter, randomized, double-blind, a

Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder

✍ Vladimir Coric; Howard H. Feldman; Dan A. Oren; Anantha Shekhar; Joseph Pultz; R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

How long should a trial of escitalopram

How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database

✍ David S. Baldwin; Dan J. Stein; Ornah T. Dolberg; Borwin Bandelow 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective To extend the knowledge of course of improvement in patients with major depressive disorder (MDD), social anxiety disorder (SAD) or generalised anxiety disorder (GAD) participating in randomised placebo‐controlled trials (RCTs) and to infer the optimal duration of initial